| EPSRC Reference: |
EP/Z532964/1 |
| Title: |
EPSRC MediForge Hub: Industry 5.0 Medicines Manufacturing Research Hub |
| Principal Investigator: |
Florence, Professor AJ |
| Other Investigators: |
| Nordon, Professor A |
Sefcik, Professor J |
Love, Professor S |
| Galindo, Professor A |
Schroeder, Professor SLM |
Brown, Dr C |
| Smith, Dr R |
Litster, Professor JD |
Bourne, Professor RA |
| Johnston, Professor BF |
Jackson, Professor G |
Adjiman, Professor CS |
| Chapman, Professor P |
Markl, Dr D |
Cardona, Dr J |
|
| Researcher Co-Investigators: |
|
| Project Partners: |
|
| Department: |
Inst of Pharmacy and Biomedical Sci |
| Organisation: |
University of Strathclyde |
| Scheme: |
Standard Research TFS |
| Starts: |
01 July 2024 |
Ends: |
30 June 2031 |
Value (£): |
11,895,078
|
| EPSRC Research Topic Classifications: |
| Artificial Intelligence |
Carbon Capture & Storage |
| Design & Testing Technology |
Drug Formulation & Delivery |
|
| EPSRC Industrial Sector Classifications: |
| Manufacturing |
Pharmaceuticals and Biotechnology |
|
| Related Grants: |
|
| Panel History: |
|
|
Summary on Grant Application Form |
We will also create a diverse, inclusive, and interdisciplinary MediForge Living Lab environment for co-creation of medicine manufacturing research, technology, open innovation and staff development (Platform 4). Core to the Hub is providing national leadership in the research, development and innovation community for Industry 5.0 medicines manufacturing to drive adoption of digital transformation CMC procedures in industry (Platform 5). The central focus of the Hub is to take the lead in the national research, development, and innovation community for Industry 5.0 medicine manufacturing, driving the digital transformation of CMC procedures for sustainable medicines manufacturing.
MediForge will facilitate the transformation of medicine development and production for affordable, sustainable healthcare; accelerate patient access to new medicines; ensure a resilient supply of quality medicines; address the climate crisis and enable the workforce of the future to thrive in a culture of open innovation and entrepreneurship for placed-based economic growth.uture workforce to realise the goals of Industry 5.0. The Hub aims to: transform our system-wide understanding of molecules to the final product through the development of:
- a novel integrated cyber-physical research infrastructure
- a world-first medicine development and manufacturing data fabric
- a reconfigurable end-to-end manufacturing testbed
This will be delivered through five research platforms, focusing on creating a system of cyber-physical platforms that integrate scale-down processes with various technologies like AI, robotics, and smart sensors (Platform 1). We will create and connect a data fabric that links material properties, process settings and final product attributes, and advanced system-wide models to inform a real-time digital twin of the entire manufacturing process (Platform 2). The real-time digital twin will drive a new flexible and resilient system for manufacturing pharmaceuticals using modular and reconfigurable technology to increase efficiency and adaptability.
|
|
Key Findings |
|
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
|
Potential use in non-academic contexts |
|
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
|
Impacts |
|
| Description |
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk |
| Summary |
|
| Date Materialised |
|
|
|
|
Sectors submitted by the Researcher |
|
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
|
| Project URL: |
|
| Further Information: |
|
| Organisation Website: |
http://www.strath.ac.uk |